Pharmacology, Toxicology and Pharmaceutical Science
Chronic Obstructive Lung Disease
100%
Placebo
12%
Biological Marker
9%
Vilanterol
8%
Fluticasone Furoate
8%
Asthma
7%
Salmeterol
7%
Disease
7%
All Cause Mortality
6%
Fluticasone Propionate
5%
Bronchodilating Agent
5%
Cardiovascular Disease
5%
Disease Exacerbation
5%
Prevalence
5%
Heart Failure
5%
Cardiovascular Risk
5%
Medicine and Dentistry
Chronic Obstructive Pulmonary Disease
80%
Forced Expiratory Volume
11%
Vilanterol
7%
Smoking
7%
Biological Marker
7%
Prevalence
6%
Airflow
6%
Asthma
6%
Fluticasone Furoate
6%
Population
5%
Diseases
5%
Symptom
5%
Disease Exacerbation
5%
Emphysema
5%
Spirometry
5%
Biochemistry, Genetics and Molecular Biology
Population
13%
Forced Expiratory Volume
11%
Smoking
11%
Population Research
5%
All Cause Mortality
5%
Prevalence
5%